|
Product complaint # (b)(4).(b)(4).Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested and the following was obtained: were the other incidents reported, please provide pc numbers? for this specific events how many sutures pull off from the needle? procedure.Only one incident occurred on one suture so they had to pull the entire box for safety reasons.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.
|
|
Date sent to the fda: 04/02/2021.Additional information: d9, h6 additional h6 component code: g07002 ¿ reported condition not confirmed.A manufacturing record evaluation was performed for the finished device lot number ppmhlc, and no non-conformances related to the reported complaint condition were identified.Additional h-3 summary: visual inspection and functional test evaluation were conducted on the returned device.Visual analysis of the returned sample determined that thirty unopened samples of product code u203h were received for evaluation.Visual inspection of unopened samples and no defects were found on the package.The samples were opened, and the swage and attachment area was noted to be as expected.The sutures were dispensed without problems and examined along the strand and no defects or damage were observed.A functional test was performed and the pull force was above the minimum requirements.The event described could not be confirmed as the device performed without any defect noted and the complaint sample was not received for evaluation.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Date sent to the fda: 04/02/2021.Corrected information: d3, g1.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|